UK Service Providers Look to the New World
The decline of financial support for the biopharmaceutical industry has been a huge blow to the contract research and manufacturing industries. According to the National Venture Capital Association, venture capital funding for the biopharmaceutical industry in the US dropped 46% in the first quarter of 2009, to just $577 million; it had averaged over $1 billion per quarter throughout this decade. [more...]
|
|
|
